NARA Discovery
Article Details
← Back to Search Results
Journal Article

High-Dose Aluminum Exposure Further Alerts Immune Phenotype in Aplastic Anemia Patients

Yao Zuo; Xiang Lu; Xiaochao Wang; Suren R. Sooranna; Liju Tao; Shiqiang Chen; Hongwen Li; Dan Huang; Guanye Nai; Hong Chen; Chunfeng Pan; Caihong Huang; Yanmin Pang
Biological Trace Element Research · Vol. 199, Issue 5 · pp. 1743-1753 · 2021

Abstract

This study explored the relationship between immunological status and clinical characteristics of aplastic anemia (AA) patients to plasma aluminum levels, which were increased after constant exposure to high levels of this metal. Sixty-two AA patients (33 cases with high and 29 cases with low or no exposure to aluminum) and 30 healthy controls were selected for this study. Aluminum in human albumin solution was measured by inductivity coupled plasma mass spectrometry. IL-10, IL-12, IL-17, and INF-γ levels were measured by enzyme-linked immunosorbent assay. The distribution of lymphocyte subsets were determined by flow cytometry. The expression levels of immunoglobulins and complement C3 and C4 were also measured. Exposure to high aluminum raised the levels of serum aluminum in AA patients ( P < 0.01). The levels of hemoglobin and complement C4 were lower in AA patients with high aluminum exposure ( P < 0.05 and < 0.01, respectively). The percentage of CD4 + T cells and the ratio of CD4 + / CD8 + T cells in peripheral blood in AA patients with high aluminum exposure were higher compared with control AA patients ( P < 0.05 in both cases), while the percentage of CD8 + T cells was significantly lower than that in non-aluminum–exposed AA patients ( P < 0.05). Compared with non-aluminum–exposed AA patients, the level of IL-10 in the high aluminum–exposed AA group was significantly higher ( P < 0.05 in both cases). The immunological and clinical characteristics of AA patients from regions of high aluminum exposure are different to those in from non-aluminum areas. These results suggest that high aluminum exposure alters the immune system in patients suffering from AA.

Bibliographic Information

JournalBiological Trace Element Research
PublisherSpringer
Publication Date2021-05-01
Publication Year2021
Volume199
Issue5
Pages1743-1753
Document TypeJournal Article
eISSN1559-0720
DOI10.1007/s12011-020-02313-6

Access Information

NARA Access Coverage1979-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12011
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.